Back to search results

Mindfulness Study for Long COVID Symptoms

This study is exploring whether a structured mindfulness intervention can help people with Long COVID (also known as Post-Acute Sequelae of SARS-CoV-2 infection or PASC). Mindfulness involves focusing on the present moment without judgment. Researchers want to see if this intervention can reduce stress, lessen Long COVID symptoms, and improve your quality of life. The intervention consists of recorded mindfulness sessions, accessed online. You might receive the intervention right away or after 8 weeks. The study will measure changes in your overall health and well-being using a survey called the PROMIS Global 10 Score after two months. The study aims to enroll 400 participants and is currently unclear on its recruitment status. You can join if you are 18 or older, have internet access, and have had COVID-19 with ongoing symptoms for at least 12 weeks.

Study design
This is an interventional study with 400 planned participants. Participants will be randomly assigned to receive the mindfulness intervention either immediately or after an 8-week delay.
What's involved
You will complete online surveys over 6 months. All participation is remote, with no in-person visits required.
Compensation
Not stated in the trial record.
Follow-up
Your overall health and well-being will be assessed at Month 2.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07140094

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Recruiting
NAAges 18+InterventionalTreatment
Columbia University
~400 participants
Updated 2026-08-31 on ClinicalTrials.gov
What's tested:Structured mindfulness intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean Score of Patient-Reported Outcomes Measurement Information System (PROMIS) Global 10 Score
Measured over Month 2

Conditions

Long COVID
Long Covid19
Post-Acute COVID-19
Post-Acute COVID-19 Syndrome
Post-Acute COVID-19 Infection
COVID Long-Haul

Explore related trials

Post-Acute Sequelae of COVID-19

NCT07140094

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Deborah Theodore, MD · PRINCIPAL_INVESTIGATOR · Columbia University

Who to contact

Deborah Theodore, MD
[email protected]
2123058739
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age \> or = 18
Willing and able to provide informed consent
Access to the internet
Self-reported history of SARS-CoV-2 infection
Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness

Exclusion

Participating in another clinical trial of an intervention for PASC symptoms
Engaged in a structured MBI

What this trial measures

  • Mean Score of Patient-Reported Outcomes Measurement Information System (PROMIS) Global 10 ScoreMonth 2

    This is to compare the difference between both groups at Month 2. The PROMIS Global 10 is a health-related quality of life measure. Raw scores range from 4 to 20. A higher score indicates better health.